Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia

RICCARDO MOIA; M. Greco; P. Boggione; M. Nicolosi; R. Bruna; A. Patriarca; Gianluca GAIDANO; M. Lunghi

doi:10.1002/ccr3.3114

Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia

RICCARDO MOIA
, M. Greco
, P. Boggione
, M. Nicolosi
, R. Bruna
, A. Patriarca
, Gianluca GAIDANO
, M. Lunghi

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.

Lingua originale	Inglese
pagine (da-a)	2293-2294
Numero di pagine	2
Rivista	Clinical Case Reports
Volume	8
Numero di pubblicazione	11
DOI	https://doi.org/10.1002/ccr3.3114
Stato di pubblicazione	Pubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

ALL
CSF xanthochromia
hepatotoxicity
pegasparaginase

Accesso al documento

10.1002/ccr3.3114

http://hdl.handle.net/11579/138312

Altri file e collegamenti

handle

Cita questo

@article{3b763b6a553c4dc7a8220a704ae76fa1,

title = "Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia",

abstract = "Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.",

keywords = "ALL, CSF xanthochromia, hepatotoxicity, pegasparaginase, ALL, CSF xanthochromia, hepatotoxicity, pegasparaginase",

author = "RICCARDO MOIA and M. Greco and P. Boggione and M. Nicolosi and R. Bruna and A. Patriarca and Gianluca GAIDANO and M. Lunghi",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Clinical Case Reports published by John Wiley \& Sons Ltd.",

year = "2020",

doi = "10.1002/ccr3.3114",

language = "English",

volume = "8",

pages = "2293--2294",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia

AU - MOIA, RICCARDO

AU - Greco, M.

AU - Boggione, P.

AU - Nicolosi, M.

AU - Bruna, R.

AU - Patriarca, A.

AU - GAIDANO, Gianluca

AU - Lunghi, M.

PY - 2020

Y1 - 2020

N2 - Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.

AB - Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.

KW - ALL

KW - CSF xanthochromia

KW - hepatotoxicity

KW - pegasparaginase

KW - ALL

KW - CSF xanthochromia

KW - hepatotoxicity

KW - pegasparaginase

UR - https://iris.uniupo.it/handle/11579/138312

U2 - 10.1002/ccr3.3114

DO - 10.1002/ccr3.3114

M3 - Article

SN - 2050-0904

VL - 8

SP - 2293

EP - 2294

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 11

ER -

Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo